INTUITIVE SURGICAL INC (ISRG) Stock Analyst Earnings Estimates
NASDAQ:ISRG - Nasdaq - US46120E6023 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 6.222B 8.97% | 7.124B 14.49% | 8.352B 17.24% | 9.97B 19.37% | 11.397B 14.31% | 13.068B 14.66% | 14.228B 8.88% | 16.692B 17.32% | 19.515B 16.91% | 20.355B 4.30% | 22.622B 11.14% | |
| EBITDA YoY % growth | 1.99B -8.06% | 2.235B 12.33% | 2.856B 27.80% | 4.14B 44.94% | 4.675B 12.92% | 5.544B 18.59% | 6.041B 8.96% | 7.421B 22.84% | 9.219B 24.23% | N/A | N/A | |
| EBIT YoY % growth | 1.597B -12.81% | 1.78B 11.45% | 2.357B 32.38% | 3.518B 49.28% | 4.051B 15.15% | 4.772B 17.80% | 5.437B 13.94% | 6.52B 19.92% | 8.069B 23.76% | N/A | N/A | |
| Operating Margin | 25.67% | 24.99% | 28.22% | 35.29% | 35.54% | 36.52% | 38.21% | 39.06% | 41.35% | N/A | N/A | |
| EPS YoY % growth | 4.69 -5.63% | 5.71 21.75% | 7.33 28.37% | 8.00 9.11% | 9.22 15.34% | 10.83 17.39% | 12.28 13.44% | 14.44 17.57% | 18.08 25.21% | 18.07 -0.06% | 19.59 8.41% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 2.03 10.13% | 2.21 -0.06% | 2.09 15.42% | 2.34 7.08% | 2.40 18.59% | 2.68 21.37% | 2.75 31.83% | 2.96 26.14% | 3.02 25.64% | 3.43 27.85% |
| Revenue Q2Q % growth | 2.448B 20.11% | 2.728B 13.03% | 2.629B 16.67% | 2.765B 13.32% | 2.814B 14.95% | 3.121B 14.41% | 3.179B 20.92% | 3.407B 23.22% | 3.463B 23.06% | 3.92B 25.60% |
| EBITDA Q2Q % growth | 1.01B 7.21% | 1.131B -8.84% | 1.036B 41.28% | 1.167B 10.37% | 1.185B 17.33% | 1.335B 18.04% | 1.37B 32.24% | 1.458B 24.94% | 1.487B 25.49% | 1.717B 28.61% |
| EBIT Q2Q % growth | 849M 46.94% | 931.54M 25.71% | 894.31M 53.21% | 1.014B 36.40% | 1.039B 22.38% | 1.167B 25.28% | 1.211B 35.41% | 1.305B 28.70% | 1.333B 28.30% | 1.517B 29.99% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 2.19 23.03% | 1.96 | 0.23 | 11.61% |
| Q1 2025 Q2Q % growth | 1.81 20.67% | 1.76 | 0.05 | 3.05% |
| Q4 2024 Q2Q % growth | 2.21 38.12% | 1.83 | 0.38 | 20.76% |
| Q3 2024 Q2Q % growth | 1.84 26.03% | 1.67 | 0.17 | 10.37% |
| Q2 2024 Q2Q % growth | 1.78 25.35% | 1.57 | 0.21 | 13.38% |
| Q1 2024 Q2Q % growth | 1.50 21.95% | 1.44 | 0.06 | 4.44% |
| Q4 2023 Q2Q % growth | 1.60 30.08% | 1.51 | 0.09 | 5.71% |
| Q3 2023 Q2Q % growth | 1.46 22.69% | 1.44 | 0.02 | 1.36% |
| Q2 2023 Q2Q % growth | 1.42 24.56% | 1.35 | 0.07 | 4.99% |
| Q1 2023 Q2Q % growth | 1.23 8.85% | 1.22 | 0.01 | 0.47% |
| Q4 2022 Q2Q % growth | 1.23 -5.38% | 1.28 | -0.05 | -3.59% |
| Q3 2022 Q2Q % growth | 1.19 | 1.14 | 0.05 | 4.23% |
| Q2 2022 Q2Q % growth | 1.14 -12.76% | 1.21 | -0.07 | -5.83% |
| Q1 2022 Q2Q % growth | 1.13 -3.69% | 1.10 | 0.03 | 2.71% |
| Q4 2021 Q2Q % growth | 1.30 8.94% | 1.30 | 0.00 | -0.36% |
| Q3 2021 Q2Q % growth | 1.19 28.88% | 1.19 | 0.00 | 0.04% |
| Q2 2021 Q2Q % growth | 1.31 253.15% | 1.04 | 0.26 | 25.38% |
| Q1 2021 Q2Q % growth | 1.17 30.85% | 0.90 | 0.28 | 31.07% |
| Q4 2020 Q2Q % growth | 1.19 2.87% | 1.06 | 0.13 | 12.35% |
| Q3 2020 Q2Q % growth | 0.92 -19.24% | 0.70 | 0.22 | 31.36% |
| Q2 2020 Q2Q % growth | 0.37 -65.85% | 0.15 | 0.22 | 152.48% |
| Q1 2020 Q2Q % growth | 0.90 3.07% | 0.87 | 0.03 | 3.65% |
| Q4 2019 Q2Q % growth | 1.16 | 1.15 | 0.01 | 1.03% |
| Q3 2019 Q2Q % growth | 1.14 | 1.02 | 0.13 | 12.42% |
| Q2 2019 Q2Q % growth | 1.08 | 0.98 | 0.11 | 10.98% |
| Q1 2019 Q2Q % growth | 0.87 | 0.92 | -0.05 | -5.22% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 2.44B 21.40% | 2.396B | 44M | 1.84% |
| Q1 2025 Q2Q % growth | 2.253B 19.19% | 2.229B | 24.4M | 1.09% |
| Q4 2024 Q2Q % growth | 2.414B 25.16% | 2.296B | 117.5M | 5.12% |
| Q3 2024 Q2Q % growth | 2.038B 16.88% | 2.041B | -2.9M | -0.14% |
| Q2 2024 Q2Q % growth | 2.01B 14.47% | 2.011B | -1.1M | -0.05% |
| Q1 2024 Q2Q % growth | 1.891B 11.46% | 1.905B | -14.4M | -0.76% |
| Q4 2023 Q2Q % growth | 1.928B 16.51% | 1.926B | 2.3M | 0.12% |
| Q3 2023 Q2Q % growth | 1.744B 11.96% | 1.802B | -58.3M | -3.24% |
| Q2 2023 Q2Q % growth | 1.756B 15.36% | 1.774B | -18.1M | -1.02% |
| Q1 2023 Q2Q % growth | 1.696B 14.01% | 1.628B | 68.2M | 4.19% |
| Q4 2022 Q2Q % growth | 1.655B 6.73% | 1.702B | -47M | -2.76% |
| Q3 2022 Q2Q % growth | 1.557B 10.98% | 1.547B | 10.4M | 0.67% |
| Q2 2022 Q2Q % growth | 1.522B 3.97% | 1.592B | -69.9M | -4.39% |
| Q1 2022 Q2Q % growth | 1.488B 15.14% | 1.455B | 32.7M | 2.25% |
| Q4 2021 Q2Q % growth | 1.551B 16.67% | 1.552B | -1.3M | -0.08% |
| Q3 2021 Q2Q % growth | 1.403B 30.21% | 1.413B | -9.7M | -0.69% |
| Q2 2021 Q2Q % growth | 1.464B 71.81% | 1.29B | 174M | 13.49% |
| Q1 2021 Q2Q % growth | 1.292B 17.52% | 1.135B | 157.1M | 13.84% |
| Q4 2020 Q2Q % growth | 1.329B 4.02% | 1.264B | 65.1M | 5.15% |
| Q3 2020 Q2Q % growth | 1.078B -4.48% | 990.39M | 87.31M | 8.82% |
| Q2 2020 Q2Q % growth | 852.1M -22.46% | 687.28M | 164.82M | 23.98% |
| Q1 2020 Q2Q % growth | 1.1B 12.92% | 1.049B | 50.5M | 4.81% |
| Q4 2019 Q2Q % growth | 1.278B | 1.263B | 14.7M | 1.16% |
| Q3 2019 Q2Q % growth | 1.128B | 1.086B | 42.2M | 3.89% |
| Q2 2019 Q2Q % growth | 1.099B | 1.053B | 45.9M | 4.36% |
| Q1 2019 Q2Q % growth | 973.7M | 992.9M | -19.2M | -1.93% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 2.08% | -2.78% | 0% | -2.65% |
| Revenue | 0.78% | 0.66% | 1.29% | 1.25% |